Skip to main content
. 2024 Jul 22;15(8):e01667-24. doi: 10.1128/mbio.01667-24

Fig 1.

Kaplan–Meier survival curve depicts percent survival over time for patients with SARS-CoV-2, S. aureus, and coinfection. A flowchart details the study design, starting with patients known to have SARS-CoV-2 PCR and S. aureus isolates.

Establishment of a biorepository of S. aureus during the early COVID-19 pandemic (a) Survival curve of patients in our cohort with SARS-CoV-2 confirmed by PCR, with S. aureus blood or respiratory culture or with both infections. Time = 0 on the day of positive S. aureus culture or in the case of SARS-CoV-2 alone, on the day of SARS-CoV-2 PCR positivity. Data were analyzed by Wilcoxon-Breslow test. (b) Generation of the cohort of patients and isolates analyzed in this study. *P < 0.05